|
1
|
Jaklitsch MT, Grondin SC and Sugarbaker
DJ: Treatment of malignant mesothelioma. World J Surg. 25:210–217.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Spagnolo F, Boutros A, Tanda E and
Queirolo P: The adjuvant treatment revolution for high-risk
melanoma patients. Semin Cancer Biol. 59:283–289. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lacy A and O'Kennedy R: Studies on
coumarins and coumarin- related compounds to determine their
therapeutic role in the treatment of cancer. Curr Pharm Des.
10:3797–3811. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Spiegel D and Classen C: Group therapy for
cancer patients: A research-based handbook of psychosocial care.
1st edition Basic Books; New York, NY: 2000
|
|
5
|
Hutchison S, Sahay B, de Mello SC, Sayour
EJ, Lejeune A, Szivek A, Livaccari AM, Fox-Alvarez S, Salute M,
Powers L and Milner RJ: Characterization of myeloid-derived
suppressor cells and cytokines GM-CSF, IL-10 and MCP-1 in dogs with
malignant melanoma receiving a GD3-based immunotherapy. Vet Immunol
Immunopathol. 216:1099122019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Indini A, Di Guardo L, Cimminiello C,
Prisciandaro M, Randon G, De Braud F and Del Vecchio M: Developing
a score system to predict therapeutic outcomes to anti-PD-1
immunotherapy in metastatic melanoma. Tumori. 105:465–473. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dolan DE and Gupta S: PD-1 pathway
inhibitors: Changing the landscape of cancer immunotherapy. Cancer
Control. 21:231–237. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Khalil DN, Smith EL, Brentjens RJ and
Wolchok JD: The future of cancer treatment: Immunomodulation, CARs
and combination immunotherapy. Nat Rev Clin Oncol. 13:273–290.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li SY, Liu Y, Xu CF, Shen S, Sun R, Du XJ,
Xia JX, Zhu YH and Wang J: Restoring anti-tumor functions of T
cells via nanoparticle-mediated immune checkpoint modulation. J
Control Release. 231:17–28. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Montagne K, Onuma Y, Ito Y, Aiki Y,
Furukawa KS and Ushida T: High hydrostatic pressure induces
pro-osteoarthritic changes in cartilage precursor cells: A
transcriptome analysis. PLoS One. 12:e01832262017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bol KF, Aarntzen EH, Pots JM, Olde
Nordkamp MA, van de Rakt MW, Scharenborg NM, de Boer AJ, van
Oorschot TG, Croockewit SA, Blokx WA, et al: Prophylactic vaccines
are potent activators of monocyte-derived dendritic cells and drive
effective anti-tumor responses in melanoma patients at the cost of
toxicity. Cancer Immunol Immunother. 65:327–339. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Klippstein R and Pozo D:
Nanotechnology-based manipulation of dendritic cells for enhanced
immunotherapy strategies. Nanomedicine. 6:523–529. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schummer V, Flindt S and Hinz T: Tumor
vaccines and peptide-loaded dendritic cells (DCs).
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz.
58:1254–1258. 2015.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gross S, Erdmann M, Haendle I, Voland S,
Berger T, Schultz E, Strasser E, Dankerl P, Janka R, Schliep S, et
al: Twelve-year survival and immune correlates in dendritic
cell-vaccinated melanoma patients. JCI Insight. 2:914382017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hu Z, Ma Y, Shang Z, Hu S, Liang K, Liang
W, Xing X, Wang Y and Du X: Improving immunotherapy for colorectal
cancer using dendritic cells combined with anti-programmed
death-ligand in vitro. Oncol Lett. 15:5345–5351.
2018.PubMed/NCBI
|
|
16
|
Rosenblatt J and Avigan D: Cellular
immunotherapy for multiple myeloma. Best Pract Res Clin Haematol.
21:559–577. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Copier J, Ward S and Dalgleish A: Cell
based cancer vaccines: Regulatory and commercial development.
Vaccine. 25 (Suppl 2):B35S–B46S. 2007. View Article : Google Scholar
|
|
18
|
Bliznyuk A, Grossman Y and Moskovitz Y:
The effect of high pressure on the NMDA receptor: Molecular
dynamics simulations. Sci Rep. 9:108142019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Weiss EM, Meister S, Janko C, Ebel N,
Schlücker E, Meyer-Pittroff R, Fietkau R, Herrmann M, Gaipl U and
Frey B: High hydrostatic pressure treatment generates inactivated
mammalian tumor cells with immunogeneic features. J Immunotoxicol.
7:194–204. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Franco I, Castillo E, Perez MD, Calvo M
and Sanchez L: Effects of hydrostatic high pressure on the
structure and antibacterial activity of recombinant human
lactoferrin from transgenic rice. Biosci Biotechnol Biochem.
76:53–59. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang Y, Dai B, Deng Y and Zhao Y: In
vitro anti-inflammatory and antioxidant activities and protein
quality of high hydrostatic pressure treated squids (Todarodes
pacificus). Food Chem. 203:258–266. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen H, Xiao G, Xu Y, Yu Y, Wu J and Zou
B: High hydrostatic pressure and Co-fermentation by lactobacillus
rhamnosus and gluconacetobacter xylinus improve flavor of
yacon-litchi-longan juice. Foods. 8:E3082019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Woo HJ, Park JB, Kang JH, Chun HH and Song
KB: Combined treatment of high hydrostatic pressure and cationic
surfactant washing to inactivate listeria monocytogenes on
fresh-cut broccoli. J Microbiol Biotechnol. 29:1240–1247. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yamamoto K: Food processing by high
hydrostatic pressure. Biosci Biotechnol Biochem. 81:672–679. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang R, Ye M, Li X, Ji L, Karwe M and
Chen H: Evaluation of high hydrostatic pressure inactivation of
human norovirus on strawberries, blueberries, raspberries and in
their purees. Int J Food Microbiol. 223:17–24. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Diehl P, Schauwecker J, Mittelmeier W and
Schmitt M: High hydrostatic pressure, a novel approach in
orthopedic surgical oncology to disinfect bone, tendons and
cartilage. Anticancer Res. 28:3877–3883. 2008.PubMed/NCBI
|
|
27
|
Barnes CA, Robertson AJ, Louis JM,
Anfinrud P and Bax A: Observation of β-amyloid peptide
oligomerization by pressure-jump NMR spectroscopy. J Am Chem Soc.
141:13762–13766. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shearer AE and Kniel KE: High hydrostatic
pressure for development of vaccines. J Food Prot. 72:1500–1508.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Golub M, Lehofer B, Martinez N, Ollivier
J, Kohlbrecher J, Prassl R and Peters J: High hydrostatic pressure
specifically affects molecular dynamics and shape of low-density
lipoprotein particles. Sci Rep. 7:460342017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Winter R and Dzwolak W:
Temperature-pressure configurational landscape of lipid bilayers
and proteins. Cell Mol Biol (Noisy-le-grand). 50:397–417.
2004.PubMed/NCBI
|
|
31
|
Winter R: Synchrotron X-ray and neutron
small-angle scattering of lyotropic lipid mesophases, model
biomembranes and proteins in solution at high pressure. Biochim
Biophys Acta. 1595:160–184. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
National Research Council (US) Committee
for the Update of the Guide for the Care and Use of Laboratory
Animals: Guide for the Care and Use of Laboratory Animals. National
Academies Press (US); Washington, DC: 2011
|
|
33
|
Varela A, Salagianni M, Galani I,
Andreakos E and Davos CH: The role of TLR7 receptors on cardiac and
vascular function of ApoE-/-mice. Eur J Echocardiography. 12 (Suppl
2):P7572011.
|
|
34
|
Leary SL, Underwood W, Anthony R, Cartner
S, Corey D, Grandin T, Greenacre C, Gwaltney-Bran S, McCrackin M
and Meyer R: AVMA guidelines for the euthanasia of animals: 2013
edition. American Veterinary Medical Association Schaumburg; IL:
2013
|
|
35
|
Zhuang X, Wu T, Zhao Y, Hu X, Bao Y, Guo
Y, Song Q, Li G, Tan S and Zhang Z: Lipid-enveloped zinc phosphate
hybrid nanoparticles for codelivery of H-2K b and H-2D b-restricted
antigenic peptides and monophosphoryl lipid A to induce antitumor
immunity against melanoma. J Control Release. 228:26–37. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
De Gruijl TD, van den Eertwegh AJ, Pinedo
HM and Scheper RJ: Whole-cell cancer vaccination: From autologous
to allogeneic tumor-and dendritic cell-based vaccines. Cancer
Immunol Immunother. 57:1569–1577. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Frey B, Schildkopf P, Rödel F, Weiss EM,
Munoz LE, Herrmann M, Fietkau R and Gaipl US: AnnexinA5 renders
dead tumor cells immunogenic-implications for multimodal cancer
therapies. J Immunotoxicol. 6:209–216. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Estrela-Llopis VR, Chevichalova AV,
Tregubova NA, Shishko ED and Litvin PM: Platinum nanoparticles with
adsorptive layer of Chlorella vulgaris polysaccharides
inactivate tumor cells of ascitic ehrlich carcinoma, ovarian cancer
and leukemia. Nanocomposites, nanophotonics, nanobiotechnology, and
applications. Fesenko O and Yatsenko L: 156. Springer Proceedings
in Physics; Springer, Cham: 2015
|
|
39
|
Hollingsworth RE and Jansen K: Turning the
corner on therapeutic cancer vaccines. NPJ Vaccines. 4:72019.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kepp O, Tesniere A, Schlemmer F, Michaud
M, Senovilla L, Zitvogel L and Kroemer G: Immunogenic cell death
modalities and their impact on cancer treatment. Apoptosis.
14:364–375. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Melief CJM, van Hall T, Arens R, Ossendorp
F and van der Burg SH: Therapeutic cancer vaccines. J Clin Invest.
125:3401–3412. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gross M and Jaenicke R: Proteins under
pressure: The influence of high hydrostatic pressure on structure,
function and assembly of proteins and protein complexes. Eur J
Biochem. 221:617–630. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Urbanova L, Hradilova N, Moserova I,
Vosahlikova S, Sadilkova L, Hensler M, Spisek R and Adkins I: High
hydrostatic pressure affects antigenic pool in tumor cells:
Implication for dendritic cell-based cancer immunotherapy. Immunol
Lett. 187:27–34. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Fucikova J, Moserova I, Truxova I,
Hermanova I, Vancurova I, Partlova S, Fialova A, Sojka L, Cartron
PF, Houska M, et al: High hydrostatic pressure induces immunogenic
cell death in human tumor cells. Int J Cancer. 135:1165–1177. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Weiss EM, Wunderlich R, Ebel N, Rubner Y,
Schlücker E, Meyer-Pittroff R, Ott OJ, Fietkau R, Gaipl US and Frey
B: Selected anti-tumor vaccines merit a place in multimodal tumor
therapies. Front Oncol. 2:1322012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Gaipl US, Munoz LE, Rödel F, Pausch F,
Frey B, Brachvogel B, von der Mark K and Pöschl E: Modulation of
the immune system by dying cells and the phosphatidylserine-ligand
annexin A5. Autoimmunity. 40:254–259. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Boonyaratanakornkit BB, Park CB and Clark
DS: Pressure effects on intra-and intermolecular interactions
within proteins. Biochim Biophys Acta. 1595:235–249. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Korn A, Frey B, Sheriff A, Gaipl U, Franz
S, Meyer-Pittroff R, Bluemelhuber G and Herrmann M: High
hydrostatic pressure inactivated human tumour cells preserve their
immunogenicity. Cell Mol Biol (Noisy-le-grand). 50:469–477.
2004.PubMed/NCBI
|
|
49
|
Frey B, Franz S, Sheriff A, Korn A,
Bluemelhuber G, Gaipl U, Voll R, Meyer-Pittroff R and Herrmann M:
Hydrostatic pressure induced death of mammalian cells engages
pathways related to apoptosis or necrosis. Cell Mol Biol
(Noisy-le-grand). 50:459–467. 2004.PubMed/NCBI
|
|
50
|
Patterson MF: Microbiology of
pressure-treated foods. J Appl Microbiol. 98:1400–1409. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Seitz C, Rückert M, Deloch L, Weiss EM,
Utz S, Izydor M, Ebel N, Schlücker E, Fietkau R, Gaipl US and Frey
B: Tumor cell-based vaccine generated with high hydrostatic
pressure synergizes with radiotherapy by generating a favorable
anti-tumor immune microenvironment. Front Oncol. 9:8052019.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Rao J, Dragulescu-Andrasi A and Yao H:
Fluorescence imaging in vivo: Recent advances. Curr Opin
Biotechnol. 18:17–25. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Chang EY, Chen CH, Ji H, Wang TL, Hung K,
Lee BP, Huang AY, Kurman RJ, Pardoll DM and Wu T: Antigen-specific
cancer immunotherapy using a GM-CSF secreting allogeneic tumor
cell-based vaccine. Int J Cancer. 86:725–730. 2000. View Article : Google Scholar : PubMed/NCBI
|
